Osteoarthritis (OA) is the most prevalent joint disease. Although many drug targets have been identified that were successful in preclinical studies, clinical trials on disease modifying OA drugs thus far have failed and pain management remains unsatisfactory. Approaches such as testing disease-related differences in expression of selected genes or proteins and analyzing their function in preclinical models has yielded a large number of pathways and molecules that are abnormal in OA. The limitations of these approaches are (i) that they provide only a selective view of molecular changes in OA and (ii) there has been no successful effort in integrating these findings into networks and prioritizing targets by their relevance as drivers of the OA process. This project leverages (i) our access to and expertise in working with human knee tissues from donors across the entire adult age spectrum and at all stages of OA development; (ii) existing and growing human knee tissue libraries; (iii) technical advances in genome wide analyses of transcriptomic changes, which provide an unbiased and comprehensive view of the genetic landscape of cartilage homeostasis and OA; (iv) our expertise in developing pipelines for integrative network analysis of multi-Omics data sets. Our hypothesis is that dysregulation transcription factors (TFs) is a major determinant of the abnormal gene expression pattern that drives OA pathogenesis. Our approach is to generate data from gene expression (mRNAseq) and enhancer activation analysis (GRO-seq) at the tissue level and more precisely at the single cell level to identify novel signatures, pathways and key regulators of cartilage homeostasis and OA.
Aim 1. The transcriptomic landscape of normal and OA human articular cartilage single cell levels. We will perform single-cell RNAseq to identify chondrocyte subpopulations in normal and OA human articular cartilage.
Aim 2. Enhancer profiling to identify drivers of pathogenic gene expression patterns in OA. Active enhancers are characterized by the presence of enhancer RNAs (eRNAs). We will use GRO-seq to assay eRNA transcription in normal and OA chondrocytes. These results will reveal pathways and networks that are disrupted in OA and identify principal regulators of OA pathogenesis.
Aim 3. Validation: Confirm differences in TF expression and activation in joint tissues and analyze function in joint tissue cells. We will assess differences in TF protein expression and activity in cartilage and other joint tissues and determine the role of candidate TFs in mediating expression of OA-associated gene patterns. Impact: To our knowledge, this is the first project to examine genome-wide mRNA expression profiles in healthy and OA-affected knee cartilage at tissue and single cell levels and linking this transcriptomic data with analysis of TF expression and activity. The study has potential discover novel pathways and principal molecular switches as therapeutic targets. Ultimately this may lead to interventions to delay or treat OA.
Osteoarthritis affects members of almost every family in the United States. This project will examine gene expression patterns at tissue and single cell levels and regulatory mechanisms that characterize cartilage homeostasis and osteoarthritis in human knees. Data and insight generated from this proposal will provide new and important insights into the pathobiology and osteoarthritis, lead to new biomarkers, and identify more promising targets for therapeutic interventions to prevent or treat osteoarthritis.
|Matsuzaki, Tokio; Alvarez-Garcia, Oscar; Mokuda, Sho et al. (2018) FoxO transcription factors modulate autophagy and proteoglycan 4 in cartilage homeostasis and osteoarthritis. Sci Transl Med 10:|
|Fisch, K M; Gamini, R; Alvarez-Garcia, O et al. (2018) Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis. Osteoarthritis Cartilage 26:1531-1538|
|Serrano, Ramon L; Chen, Liang-Yu; Lotz, Martin K et al. (2018) Impaired Proteasomal Function in Human Osteoarthritic Chondrocytes Can Contribute to Decreased Levels of SOX9 and Aggrecan. Arthritis Rheumatol 70:1030-1041|
|Alvarez-Garcia, Oscar; Matsuzaki, Tokio; Olmer, Merissa et al. (2018) FOXO are required for intervertebral disk homeostasis during aging and their deficiency promotes disk degeneration. Aging Cell 17:e12800|
|Miyaki, Shigeru; Lotz, Martin K (2018) Extracellular vesicles in cartilage homeostasis and osteoarthritis. Curr Opin Rheumatol 30:129-135|
|Lee, Kwang Il; Olmer, Merissa; Baek, Jihye et al. (2018) Platelet-derived growth factor-coated decellularized meniscus scaffold for integrative healing of meniscus tears. Acta Biomater 76:126-134|
|Shen, T; Alvarez-Garcia, O; Li, Y et al. (2017) Suppression of Sestrins in aging and osteoarthritic cartilage: dysfunction of an important stress defense mechanism. Osteoarthritis Cartilage 25:287-296|
|Alvarez-Garcia, Oscar; Matsuzaki, Tokio; Olmer, Merissa et al. (2017) Age-related reduction in the expression of FOXO transcription factors and correlations with intervertebral disc degeneration. J Orthop Res 35:2682-2691|
|Alvarez-Garcia, Oscar; Matsuzaki, Tokio; Olmer, Merissa et al. (2017) Regulated in Development and DNA Damage Response 1 Deficiency Impairs Autophagy and Mitochondrial Biogenesis in Articular Cartilage and Increases the Severity of Experimental Osteoarthritis. Arthritis Rheumatol 69:1418-1428|
|Hasei, Joe; Teramura, Takeshi; Takehara, Toshiyuki et al. (2017) TWIST1 induces MMP3 expression through up-regulating DNA hydroxymethylation and promotes catabolic responses in human chondrocytes. Sci Rep 7:42990|
Showing the most recent 10 out of 18 publications